|
To make an appointment
617-724-1396
Surgical Oncologists have undergone additional
specialty training in oncology, and
offer the highest degree of specialization
and expertise. Cancer surgery is generally
considered complex surgery and published
data have demonstrated that hospitals
and surgeons with the highest volume
experience with specific operations
have the lowest complication and death
rates. Recognizing the relationship
between frequency of performing an operation
and the quality of outcomes, each surgeon
in the Division of Surgical Oncology
focuses his or her clinical practice
on the management of one or two diseases.
The Melanoma/Skin Cancer Surgery Program
in Surgical Oncology at Massachusetts
General Hospital offers expert melanoma
surgery in the context of a multi-disciplinary
team. Melanoma specialists in Surgical
Oncology provide surgical services for
patients in the Internationally recognized
Massachusetts General Hospital Pigmented
Lesion Clinic.
Patients with melanomas are evaluated
in the Center
for Melanoma's multidisciplinary
sessions, where they can meet with
a surgeon, medical oncologist, dermatologist,
have their pathology slides reviewed
by a melanoma dermatopathologist,
and receive definitive skin cancer
treatment recommendations in a single
visit. This multi-disciplinary team
are on the leading edge in melanoma
detection, prevention, and treatment,
and offer participation in many clinical
trials. The melanoma surgeons in Surgical
Oncology are highly specialized, highly
experienced, and nationally recognized
experts. Specialized operations offered
by melanoma surgeons in Surgical Oncology
include:
- Surgery for primary melanomas
- Plastic surgical reconstructions
- Lymphatic mapping and sentinel node
biopsy
- Lymph node dissections
- Hyperthermic isolated limb perfusion
with melphalan for in transit metastases
- Hyperthermic isolated liver perfusion
for patients with ocular melanoma
liver metastases
Genetic counseling is offered through the
Center
for Cancer Risk Analysis - Melanoma
Genetics Program to assess hereditary
risk in young patients and patients with
strong family histories of melanoma.
Clinical Trials
& Research
Clinical trials to assess new treatment
regimens are offered to patients. All
of the clinical trials available for patients
at Dana-Farber Cancer Institute are available
for patients at the Cancer Center as a
result of a completely integrated clinical
trials program.
To find a clinical
trial >>>
The Surgical Oncology Research Laboratories maintain a robust
basic science research program to develop new and effective
therapies for patients with melanoma. A wide variety of educational
and support services are available for patients and their
families as they go through diagnosis, treatment and recovery.
Surgical Oncology
Team
Surgeons in the Division of Surgical
Oncology who specialize in skin cancer
and melanoma surgery are faculty members
of Harvard Medical School and regularly
teach other physicians in Continuing
Medical Education.
Antonia Stephen MD
Kenneth Tanabe, MD
|
